CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-03-26 | Pecora Andrew L Director | Grant or award | +848 | $3.08 | $3K | 343,379 |
| 2015-03-18 | Wei Eric Director | Sale | −100,000 | $3.20 | $320K | 2,122,988 |
| 2015-03-12 | Pecora Andrew L Director | Grant or award | +688 | $3.80 | $3K | 342,531 |
| 2015-02-26 | Pecora Andrew L Director | Grant or award | +6.72 | $3.89 | $26 | 341,843 |
| 2015-02-12 | Pecora Andrew L Director | Grant or award | +753 | $3.47 | $3K | 339,456 |
| 2015-02-12 | Pecora Andrew L Director | Grant or award | +1,715 | $3.77 | $6K | 341,171 |
| 2015-02-05 | VACZY CATHERINE M General Counsel | Grant or award | +30,000 | 79,359 | ||
| 2015-02-05 | VACZY CATHERINE M General Counsel | Shares withheld for taxes | −12,096 | $3.54 | $43K | 67,263 |
| 2015-01-29 | Pecora Andrew L Director | Grant or award | +746 | $3.50 | $3K | 347,508 |
| 2015-01-22 | TRABER PETER G Director | Grant or award · Stock Option (right to purchase) | +26,500 | 26,500 | ||
| 2015-01-16 | BERMAN RICHARD J Director | Grant or award | +10,766 | 28,766 | ||
| 2015-01-16 | Mazzo David J Chief Executive Officer | Grant or award | +290,078 | 290,078 | ||
| 2015-01-16 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −130,535 | $3.48 | $454K | 159,543 |
| 2015-01-16 | Mazzo David J Chief Executive Officer | Returned to the company · Stock Option (right to purchase) | −220,000 | 400,000 | ||
| 2015-01-16 | Mazzo David J Chief Executive Officer | Returned to the company · Stock Option (right to purchase) | −200,000 | 0 | ||
| 2015-01-16 | VATERS ROBERT S President & CFO | Grant or award | +137,028 | 137,028 | ||
| 2015-01-16 | VATERS ROBERT S President & CFO | Shares withheld for taxes | −61,663 | $3.48 | $215K | 75,365 |
| 2015-01-16 | VATERS ROBERT S President & CFO | Returned to the company · Stock Option (right to purchase) | −80,000 | 400,000 | ||
| 2015-01-16 | VATERS ROBERT S President & CFO | Returned to the company · Stock Option (right to purchase) | −120,000 | 0 | ||
| 2015-01-16 | Smith Robin L Exec. Chairman of the Board | Grant or award | +39,276 | 329,410 |
Page 19 of 24 · 477 trades